An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab.

Source:http://linkedlifedata.com/resource/pubmed/id/14695424

N. Engl. J. Med. 2003 Dec 25 349 26 2570-2; discussion 2570-2

Download in:

View as

Triples

General Info

PMID
14695424